Page last updated: 2024-09-04

resiquimod and Cancer of Lung

resiquimod has been researched along with Cancer of Lung in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Gu, FF; Hu, Y; Li, M; Liang, JY; Liu, L; Liu, YY; Wang, Y; Wu, JJ; Zhang, K; Zhang, YA1
Bahmani, B; Bui, JD; DeTeresa, E; Fang, RH; Gao, W; Gong, H; Haushalter, KJ; Luk, BT; Previti, M; Zhang, J; Zhang, L; Zhou, J1
Ahn, JS; Ahn, MJ; Ha, SJ; Heo, JY; Kim, JE; Kim, MS; Kim, S; Kim, SY; Koh, J; Ku, BM; Lee, KY; Lee, SH; Lee, SN; Lim, YT; Park, K; Park, YM; Sun, JM; Yang, S1

Other Studies

3 other study(ies) available for resiquimod and Cancer of Lung

ArticleYear
Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation.
    Cancer immunology, immunotherapy : CII, 2020, Volume: 69, Issue:5

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Communication; Cell Differentiation; Dendritic Cells; Humans; Imidazoles; Lipopolysaccharides; Lung Neoplasms; Lymphocyte Activation; Macrophages; Phagocytosis; Pleural Effusion, Malignant; Primary Cell Culture; Th1 Cells; Toll-Like Receptors; Tumor Cells, Cultured

2020
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors.
    Nature communications, 2021, 03-31, Volume: 12, Issue:1

    Topics: Animals; Blood Platelets; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cells, Cultured; Female; HT29 Cells; Humans; Imidazoles; Immunotherapy; Lung Neoplasms; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Treatment Outcome; Tumor Microenvironment

2021
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
    Nanomedicine : nanotechnology, biology, and medicine, 2021, Volume: 37

    Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Emulsions; Humans; Imidazoles; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymphocyte Activation; Mice; Programmed Cell Death 1 Receptor; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment

2021